Glazer Capital's new 5.49% passive stake adds a notable institutional holder to BLFS. Monitor for any future conversion to a 13D or increased activity, though the filing explicitly disclaims activist intent. The presence of multiple institutional holders (T. Rowe Price, Casdin Capital) suggests continued institutional interest.
Price Chart
Executive Summary
Glazer Capital, LLC disclosed a new 5.49% passive stake in BioLife Solutions Inc. via Schedule 13G, holding 2,685,520 shares as of September 17, 2026. This is a new position for Glazer Capital, which joins T. Rowe Price and Casdin Capital as notable institutional holders. The filing indicates no intent to influence control, consistent with a passive investment.
Key Financial Metrics
Key Facts
- Glazer Capital, LLC filed a new Schedule 13G disclosing beneficial ownership of 2,685,520 shares of BioLife Solutions Inc. common stock.
- The stake represents 5.49% of shares outstanding as of September 17, 2026.
- Paul J. Glazer, Managing Member of Glazer Capital, is also a reporting person with the same beneficial ownership.
- Glazer Capital certifies the shares were not acquired with the purpose of changing or influencing control of the issuer.
- This is a new position; no prior Glazer Capital 13G filings for BLFS were found in the provided context.
Financial Impact
New 5.49% passive stake valued at approximately $2.7 million based on 2,685,520 shares (no per-share price provided in filing).
Risk Factors
- Glazer Capital could convert to an activist 13D filing if circumstances change, though the current filing disclaims such intent.
- Passive stake does not provide a catalyst for near-term price movement.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001076809-26-000101 |
| Document: 0001076809-26-000101-index.html | 0001076809-26-000101 |
| Document: 0001076809-26-000101.txt | 0001076809-26-000101 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | 15-12G | — | awaiting T+20 | — | — |
Oct 13, 2026 13d ago | EFFECT | — | awaiting T+20 | — | — |
Oct 13, 2026 13d ago | EFFECT | — | awaiting T+20 | — | — |
Oct 6, 2026 20d ago | 8-K | $39.00 | awaiting T+20 | — | — |
Sep 30, 2026 26d ago | 425 | $38.85 | awaiting T+20 | — | — |
Sep 30, 2026 26d ago | DEFA14A | $38.85 | awaiting T+20 | — | — |
Sep 24, 2026 4w ago | SC 13G | $38.58 | awaiting T+20 | — | — |
Sep 4, 2026 7w ago | DEFM14A | $35.38 $38.61 | ▲ +9.13% | ▲ +7.42% | — |
Jun 3, 2026 20w ago | 8-K | $27.25 $28.11 | ▲ +3.16% | ▲ +4.16% | — |
Apr 28, 2026 25w ago | 10-K/A | $19.99 $25.25 | ▲ +26.31% | ▲ +20.26% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers